.

Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Indium in-111 pentetreotide kit - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for indium in-111 pentetreotide kit?

Indium in-111 pentetreotide kit is the generic ingredient in one branded drug marketed by Mallinkrodt Nuclear and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Indium in-111 pentetreotide kit has twelve patent family members in eight countries.

There are twenty-three drug master file entries for indium in-111 pentetreotide kit. Two suppliers are listed for this compound.

Summary for Generic Name: indium in-111 pentetreotide kit

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list23
Suppliers / Packagers: see list2
Clinical Trials: see list253
Drug Prices:see low prices
DailyMed Link:indium in-111 pentetreotide kit at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
OCTREOSCAN
indium in-111 pentetreotide kit
INJECTABLE;INJECTION020314-001Jun 2, 1994RXYesYes6,123,916► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indium in-111 pentetreotide kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear
OCTREOSCAN
indium in-111 pentetreotide kit
INJECTABLE;INJECTION020314-001Jun 2, 19945,384,113► Subscribe
Mallinkrodt Nuclear
OCTREOSCAN
indium in-111 pentetreotide kit
INJECTABLE;INJECTION020314-001Jun 2, 19945,753,627► Subscribe
Mallinkrodt Nuclear
OCTREOSCAN
indium in-111 pentetreotide kit
INJECTABLE;INJECTION020314-001Jun 2, 19945,776,894► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: indium in-111 pentetreotide kit

Country Document Number Estimated Expiration
Italy1244496► Subscribe
Germany4104308► Subscribe
Hong Kong43497► Subscribe
Japan3288055► Subscribe
United Kingdom2241167► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc